Keywords: ایماتینیب; mast cell leukemia; midostaurin; imatinib; masitinib; BLU-285;
مقالات ISI ایماتینیب (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ایماتینیب; Chronic myeloid leukemia; Suboptimal response; Nilotinib; Imatinib;
Keywords: ایماتینیب; Cardiopulmonary remodeling; Imatinib; Sunitinib; Pulmonary arterial hypertension;
Keywords: ایماتینیب; GISTs; Gastrointestinal stromal tumours; GI; Gastrointestinal tract; TEM; Transanal Endoscopic Microsurgery; TEO; transanal endoscopic operations; Systematic review; Rectal GIST; Imatinib; Sphincter-sparing surgery;
Keywords: ایماتینیب; KIT mutations; KIT D816V; Cutaneous mastocytosis; Systemic mastocytosis; Imatinib; Midostaurin; Avapritinib;
Keywords: ایماتینیب; Dasatinib; Deep molecular response; Imatinib; Minimal residual disease; Nilotinib;
Keywords: ایماتینیب; Acute myeloid leukemia; Philadelphia chromosome; Imatinib; inv(16); t(9;22);
Keywords: ایماتینیب; Congenital diaphragmatic hernia; CDH; Nitrofen; Retinoic acid; Imatinib;
Keywords: ایماتینیب; Imatinib; Multi-walled carbon nanotubes; Screen-printed electrodes; Derivative voltammetry; Urine determination;
Keywords: ایماتینیب; Palmoplantar hyperkeratosis; Imatinib; Nail dystrophy; Hyperkératose palmoplantaire; Imatinib; Dystrophie des ongles;
Keywords: ایماتینیب; CT; Computed tomography; GIST; Gastrointestinal stromal tumor; Case report; Gastrointestinal stromal tumour; Haemoperitoneum; Imatinib; Small intestine; Tumour rupture;
Keywords: ایماتینیب; Allogeneic stem cell transplantation; BCR-ABL; chronic myeloid leukaemia; dasatinib; imatinib; nilotinib; Philadelphia chromosome; ponatinib; quantitative RT-PCR; tyrosine kinase inhibitors;
Keywords: ایماتینیب; Imatinib; Molecular response; Chronic myeloid leukemia; Q-PCR; Tyrosine kinase inhibitor;
Keywords: ایماتینیب; Acute lymphoblastic leukemia; Philadelphia chromosome; Tyrosine kinase inhibitor; Imatinib; Dasatinib; Ponatinib;
Keywords: ایماتینیب; Imatinib; Folliculogenesis; Oogenesis; Rat; Ovary;
Keywords: ایماتینیب; Chronic myeloid leukemia; Tyrosine kinase Inhibitor; Imatinib; BCR-ABL; Molecular response;
Keywords: ایماتینیب; cabozantinib; depigmentation; dyspigmentation; hyperpigmentation; hypopigmentation; imatinib; ipilimumab; nivolumab; pazopanib; pembrolizumab; pigmentary; repigmentation; sorafenib; sunitinib; vitiligo; AE; adverse event; Bcr-abl; breakpoint cluster regio
Keywords: ایماتینیب; CHF; congestive heart failure; KIM; kinase interacting motif; JNK; c-Jun N-terminal Kinase; ATP; adenosine triphosphate; FRET; fluorescence resonance energy transfer; OCR; oxygen consumption rate; TMRM; tetramethylrhodamine methyl ester; eIF2α; elongatio
Keywords: ایماتینیب; Gastrointestinal stromal tumors; Imatinib; Tyrosine kinase inhibitors;
Keywords: ایماتینیب; AZ; acetazolamide; IM; imatinib; EAC; Ehrlich ascites carcinoma; PDGF-A; platelet derived growth factor-A; TSP-1; thrombospondin-1; VEGF; vascular endothelial growth factor; NO; nitric oxide; MMP; matrix metalloproteinase; MAPK; mitogen activated protein
Keywords: ایماتینیب; Gastrointestinal stromal tumor; GIST; Gastric mass; Abdominal tumor; Tyrosine kinase inhibitor; TKIs; Imatinib; Sunitinib;
Keywords: ایماتینیب; Systemic mastocytosis; Hypereosinophilic syndrome; Tyrosine kinase inhibitor; FIP1L1-PDGFRA; FGFR1; JAK2; Imatinib; Midostaurin;
Keywords: ایماتینیب; Carbon dots; Characterization; Imatinib; Determination
Keywords: ایماتینیب; Endometriosis; Imatinib; Ovarian reserve
Keywords: ایماتینیب; Acute lymphoblastic leukemia; ALL; Allogeneic; Cytogenetics; Dasatinib; Imatinib; Minimal residual disease; MRD; Nilotinib; Philadelphia chromosome positive; Ph+; Ponatinib; Stem cell transplant; TKI; Tyrosine kinase inhibitor;
Keywords: ایماتینیب; Nanoparticles; Doxorubicin; Vinblastine; Imatinib; Pemetrexed; Chitosan; Emulsion; Tumor; Cancer; Anticancer; P-gp; Efflux;
Keywords: ایماتینیب; Chronic myelogenous leukemia; K562; KG-1a; Imatinib; Synthesis
Keywords: ایماتینیب; Anticancer drug; Imatinib; Anodically pretreated boron-doped diamond electrode; Voltammetry; Urine
Keywords: ایماتینیب; Mast cell; mastocytosis; well differentiated; KIT; imatinib; ASM; Aggressive systemic mastocytosis; BM; Bone marrow; CM; Cutaneous mastocytosis; CPA; Carboxypeptidase A; DCM; Diffuse cutaneous mastocytosis; FACS; Fluorescence-activated cell sorting; FSC;
Keywords: ایماتینیب; Cure; Dasatinib; Imatinib; Molecular remission; Nilotinib;
Keywords: ایماتینیب; Gastrointestinal stromal tumor; Neoadjuvant therapy; Adjuvant therapy; Imatinib; Surgery;
Keywords: ایماتینیب; Pulmonary arterial hypertension; Serotonin; Statins; Vasoactive intestinal polypeptide; Imatinib; Drug development;
Keywords: ایماتینیب; Cytostatic agents; Emerging contaminants; Environmental samples; Liquid chromatography; Gas chromatography; 5-FU; 5-Fluorouracil; ACT-D; actinomycin-D; A-GLU; Aminoglutethimide; APCI; atmospheric pressure chemical ionization; APPI; atmospheric pressure ph
Keywords: ایماتینیب; Drug-induced immune thrombocytopenia; Imatinib; Myelosuppression; Thrombocytopenia; Tyrosine kinase inhibitor
Keywords: ایماتینیب; hipereozynofilia; zespół hipereozynofilowy; klasyfikacja; leczenie; imatynib; kortykosteroidyHypereosinophilia; Hypereosinophilic syndromes; Classification; Treatment; Imatinib; Corticosteroids
Keywords: ایماتینیب; Adherence; Dasatinib; Frequency of response assessments; Imatinib; Nilotinib;
Keywords: ایماتینیب; Chordomas; Review; Molecular targeted therapies; Imatinib
Keywords: ایماتینیب; Chronic myeloid leukemia; Accelerated phase; Imatinib; Prognostic factor; Mortality
Keywords: ایماتینیب; Chronic myeloid leukemia; Imatinib; Hydroxyurea; Treatment interruption
Keywords: ایماتینیب; Chronic myeloid leukemia; Imatinib; Early molecular response;
Keywords: ایماتینیب; Melanoma mucoso; c-KIT; Imatinib; Melanoma de cabeza y cuello; Melanoma ano-rectal; Melanoma vulvo-vaginalMucosal melanoma; c-KIT; Imatinib; Head and neck melanoma; Anorectal melanoma; Vulvovaginal melanoma
Keywords: ایماتینیب; Canine; Feline; Imatinib; KIT mutations; Mast cell tumours;
Keywords: ایماتینیب; pulmonary arterial hypertension; imatinib; safety; long-term; efficacy;
Keywords: ایماتینیب; Imatinib; Pregnant rat; Fetuses; Congenital deformities; Skeleton
Keywords: ایماتینیب; GIST; gastrointestinal stromal tumor; KIT; mast/stem cell growth factor receptor Kit; PDGFRA; platelet-derived growth factor receptor alpha; RTK; receptor tyrosine kinase; EGFR; epidermal growth factor receptor; PI3K; phosphatidylinositol 3-kinase; Akt; p
Keywords: ایماتینیب; Eosinophilia; PDGFRA; PDGFRB; Chronic eosinophilic leukemia; Hypereosinophilic syndrome; Imatinib;
Keywords: ایماتینیب; Tyrosine kinase inhibitors; Nilotinib; Imatinib; Quantum mechanics; Binding energies; Error assessment
Keywords: ایماتینیب; AKAP; A-Kinase Anchoring Protein; ALL; acute lymphoblastic leukemia; A.S.; activation segment; CDK; cyclin-dependent kinase; CML; chronic myelogenous leukemia; C-spine; catalytic spine; EGFR; epidermal growth factor receptor; FGFR; fibroblast growth facto
Keywords: ایماتینیب; EGIST; GIST; Imatinib; Complete pathological response
Keywords: ایماتینیب; Imatinib; Tradescantia; Allium; Micronucleus; Root growth; Pollen abortion